Description
Pharmaceutical 2-Amino-6-Chloropurine-9-Riboside CAS 2004-07-1
Description
| Product Name: | 2-Amino-6-chloropurine-9-riboside | Other Name: | 2-AMINO-6-CHLORO-9-(BETA-D-RIBOFURANOSYL)PURINE |
|---|---|---|---|
| CAS No: | 2004-07-1 | Purity: | 99% Min |
| Shelf Life: | 2 Years | Application: | Medication |
| Sample: | Available | Storage: | Cool And Dry Place |
| Appearance: | Crystalline Powder | ||
| High Light: |
Pharmaceutical 2-Amino-6-Chloropurine-9-Riboside, 2-Amino-6-Chloropurine-9-Riboside CAS 2004-07-1, Pharmaceutical Intermediat CAS 2004-07-1 |
||
Pharmaceutical Intermediate CAS 2004-07-1 2 – Amino – 6 – Chloropurine – 9 – Riboside
Product Introduction
Name: 2-Amino-6-chloropurine-9-riboside
English synonym: 2-AMINO-6-CHLORO-9-(BETA-D-RIBOFURANOSYL)PURINE
CAS number: 2004-07-1
Molecular formula: C10H12ClN5O4
Molecular weight: 301.69
EINECS Number: 217-905-3
Product Description
Melting point: 165-167°C(dec.)(lit.)
Boiling point: 729.9±70.0°C (Predicted)
Density: 1.8359 (rough estimate)
Refractive index: -38°(C=0.1,H2O)
Storage conditions: Keep in dark place, Inert atmosphere, Store in freezer, under -20°C
Acidity coefficient (pKa): 13.05±0.70 (Predicted)
Form: Powder
Color: White to Off-white
Product Function
Purine nucleoside derivatives have been a field of great concern for many researchers for more than half a century due to their unique structures and good biological activities in anti-virus, anti-cancer, blood pressure lowering and anti-platelet aggregation. These studies are mainly on the modification of purine nucleoside sugar structure or base structure, or both.
